miR-103-3p was down-regulated in EAT from CAD patients, and was associated with negative regulation of inflammatory pathways and promotion of adipocyte metabolism by targeting CCL13 inhibition [25]. The gene discussed is CCL13; the disease is coronary artery disorder.